Occurrence of neuronal inclusions combined with increased nigral expression of α-synuclein within dopaminergic neurons following treatment with amphetamine derivatives in mice

Francesco Fornai, Paola Lenzi, Michela Ferrucci, Gloria Lazzeri, Adolfo Bandettini Di Poggio, Gianfranco Natale, Carla L. Busceti, Francesca Biagioni, Mario Giusiani, Stefano Ruggieri, Antonio Paparelli

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

In recent years several clinical and research findings have demonstrated the involvement of the presynaptic protein α-synuclein in a variety of neurodegenerative disorders which are known as synucleinopathies. Although the function of this protein in the physiology of the cell remains unknown, it is evident that both genetic alterations or a mere overexpression of the native molecule produces a degeneration of nigral dopamine-containing neurons leading to movement disorders, as demonstrated in inherited Parkinson's disease. In the present study, we investigated whether widely abused drugs such as methamphetamine and methylenedioxymethamphetamine (ecstasy), which are known to damage the nigrostriatal dopamine pathway of mice, increase the expression of α-synuclein within dopamine neurons of the substantia nigra pars compacta. The results of this study demonstrate that nigrostriatal dopamine denervation and occurrence of intracellular inclusions in nigral neurons produced by amphetamine derivatives are related to increased expression of α-synuclein within dopamine neurons of the substantia nigra. This lends substance to the hypothesis that increased amounts of native α-synuclein may be per se a detrimental factor for the dopamine neurons.

Original languageEnglish
Pages (from-to)405-413
Number of pages9
JournalBrain Research Bulletin
Volume65
Issue number5
DOIs
Publication statusPublished - May 15 2005

Fingerprint

Synucleins
Dopaminergic Neurons
Substantia Nigra
Amphetamine
Dopamine
N-Methyl-3,4-methylenedioxyamphetamine
Cell Physiological Phenomena
Methamphetamine
Movement Disorders
Denervation
Neurodegenerative Diseases
Parkinson Disease
Proteins
Neurons
Research
Pharmaceutical Preparations

Keywords

  • Ecstasy
  • Methamphetamine
  • Methylenedioxymethamphetamine
  • Parkinson's disease
  • Substantia nigra

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Occurrence of neuronal inclusions combined with increased nigral expression of α-synuclein within dopaminergic neurons following treatment with amphetamine derivatives in mice. / Fornai, Francesco; Lenzi, Paola; Ferrucci, Michela; Lazzeri, Gloria; Di Poggio, Adolfo Bandettini; Natale, Gianfranco; Busceti, Carla L.; Biagioni, Francesca; Giusiani, Mario; Ruggieri, Stefano; Paparelli, Antonio.

In: Brain Research Bulletin, Vol. 65, No. 5, 15.05.2005, p. 405-413.

Research output: Contribution to journalArticle

Fornai, Francesco ; Lenzi, Paola ; Ferrucci, Michela ; Lazzeri, Gloria ; Di Poggio, Adolfo Bandettini ; Natale, Gianfranco ; Busceti, Carla L. ; Biagioni, Francesca ; Giusiani, Mario ; Ruggieri, Stefano ; Paparelli, Antonio. / Occurrence of neuronal inclusions combined with increased nigral expression of α-synuclein within dopaminergic neurons following treatment with amphetamine derivatives in mice. In: Brain Research Bulletin. 2005 ; Vol. 65, No. 5. pp. 405-413.
@article{c99777043f8d477cbf6aa98e1ed761ea,
title = "Occurrence of neuronal inclusions combined with increased nigral expression of α-synuclein within dopaminergic neurons following treatment with amphetamine derivatives in mice",
abstract = "In recent years several clinical and research findings have demonstrated the involvement of the presynaptic protein α-synuclein in a variety of neurodegenerative disorders which are known as synucleinopathies. Although the function of this protein in the physiology of the cell remains unknown, it is evident that both genetic alterations or a mere overexpression of the native molecule produces a degeneration of nigral dopamine-containing neurons leading to movement disorders, as demonstrated in inherited Parkinson's disease. In the present study, we investigated whether widely abused drugs such as methamphetamine and methylenedioxymethamphetamine (ecstasy), which are known to damage the nigrostriatal dopamine pathway of mice, increase the expression of α-synuclein within dopamine neurons of the substantia nigra pars compacta. The results of this study demonstrate that nigrostriatal dopamine denervation and occurrence of intracellular inclusions in nigral neurons produced by amphetamine derivatives are related to increased expression of α-synuclein within dopamine neurons of the substantia nigra. This lends substance to the hypothesis that increased amounts of native α-synuclein may be per se a detrimental factor for the dopamine neurons.",
keywords = "Ecstasy, Methamphetamine, Methylenedioxymethamphetamine, Parkinson's disease, Substantia nigra",
author = "Francesco Fornai and Paola Lenzi and Michela Ferrucci and Gloria Lazzeri and {Di Poggio}, {Adolfo Bandettini} and Gianfranco Natale and Busceti, {Carla L.} and Francesca Biagioni and Mario Giusiani and Stefano Ruggieri and Antonio Paparelli",
year = "2005",
month = "5",
day = "15",
doi = "10.1016/j.brainresbull.2005.02.022",
language = "English",
volume = "65",
pages = "405--413",
journal = "Brain Research Bulletin",
issn = "0361-9230",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Occurrence of neuronal inclusions combined with increased nigral expression of α-synuclein within dopaminergic neurons following treatment with amphetamine derivatives in mice

AU - Fornai, Francesco

AU - Lenzi, Paola

AU - Ferrucci, Michela

AU - Lazzeri, Gloria

AU - Di Poggio, Adolfo Bandettini

AU - Natale, Gianfranco

AU - Busceti, Carla L.

AU - Biagioni, Francesca

AU - Giusiani, Mario

AU - Ruggieri, Stefano

AU - Paparelli, Antonio

PY - 2005/5/15

Y1 - 2005/5/15

N2 - In recent years several clinical and research findings have demonstrated the involvement of the presynaptic protein α-synuclein in a variety of neurodegenerative disorders which are known as synucleinopathies. Although the function of this protein in the physiology of the cell remains unknown, it is evident that both genetic alterations or a mere overexpression of the native molecule produces a degeneration of nigral dopamine-containing neurons leading to movement disorders, as demonstrated in inherited Parkinson's disease. In the present study, we investigated whether widely abused drugs such as methamphetamine and methylenedioxymethamphetamine (ecstasy), which are known to damage the nigrostriatal dopamine pathway of mice, increase the expression of α-synuclein within dopamine neurons of the substantia nigra pars compacta. The results of this study demonstrate that nigrostriatal dopamine denervation and occurrence of intracellular inclusions in nigral neurons produced by amphetamine derivatives are related to increased expression of α-synuclein within dopamine neurons of the substantia nigra. This lends substance to the hypothesis that increased amounts of native α-synuclein may be per se a detrimental factor for the dopamine neurons.

AB - In recent years several clinical and research findings have demonstrated the involvement of the presynaptic protein α-synuclein in a variety of neurodegenerative disorders which are known as synucleinopathies. Although the function of this protein in the physiology of the cell remains unknown, it is evident that both genetic alterations or a mere overexpression of the native molecule produces a degeneration of nigral dopamine-containing neurons leading to movement disorders, as demonstrated in inherited Parkinson's disease. In the present study, we investigated whether widely abused drugs such as methamphetamine and methylenedioxymethamphetamine (ecstasy), which are known to damage the nigrostriatal dopamine pathway of mice, increase the expression of α-synuclein within dopamine neurons of the substantia nigra pars compacta. The results of this study demonstrate that nigrostriatal dopamine denervation and occurrence of intracellular inclusions in nigral neurons produced by amphetamine derivatives are related to increased expression of α-synuclein within dopamine neurons of the substantia nigra. This lends substance to the hypothesis that increased amounts of native α-synuclein may be per se a detrimental factor for the dopamine neurons.

KW - Ecstasy

KW - Methamphetamine

KW - Methylenedioxymethamphetamine

KW - Parkinson's disease

KW - Substantia nigra

UR - http://www.scopus.com/inward/record.url?scp=20144389039&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20144389039&partnerID=8YFLogxK

U2 - 10.1016/j.brainresbull.2005.02.022

DO - 10.1016/j.brainresbull.2005.02.022

M3 - Article

VL - 65

SP - 405

EP - 413

JO - Brain Research Bulletin

JF - Brain Research Bulletin

SN - 0361-9230

IS - 5

ER -